University of Washington: Cognitive Dysfunction trials

The registry lists 14 Cognitive Dysfunction studies with University of Washington as lead sponsor. 1 are open to participants now and 4 have results posted.

Phase 2 4Phase 3 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit SurvivorsRecruitingNCT06411561Not applicable
• Innovations in Dementia Empowerment and ActionCompletedNCT03550131Not applicableResults posted
• A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and ComorbidityCompletedNCT02655354Not applicableResults posted
• A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity PilotCompletedNCT02335125Not applicableResults posted
• Hormone and Information Processing StudyCompletedNCT00539305Phase 3Results posted
• The "Let's Talk Tech" Tool to Support Decision Making About Technology UseCompletedNCT06817122Not applicable
• Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their CaregiversActive, not recruitingNCT05596760Not applicable
• Optimal Timing of Computerized Cognitive Training for Older Intensive Care Unit SurvivorsActive, not recruitingNCT05467410Not applicable
• University of Washington Alzheimer's Disease Research Center (UW ADRC) Imaging & Biomarker CoreStatus unknownNCT04437290
• Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 DaysCompletedNCT01547169Phase 2
• Exercise and Activities for Independent Living With Mild Cognitive Impairment (MCI)CompletedNCT00446394Not applicable
• SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)CompletedNCT00438568Phase 2
• SMART: Somatotrophics, Memory, and Aging Research TrialCompletedNCT00257712Phase 2
• Rosiglitazone Effects on Cognition for Adults in Later LifeStatus unknownNCT00242593Phase 2